Prvi modifikovani virus protiv raka napredovao do kliničkih studija na ljudima. Napada ćelije raka debelog creva, dojke, pluća, jajnika i pankreasa.
Oncolytic virus therapy is made possible once viruses found in nature are genetically modified to infect, replicate in and kill cancer cells, while sparing healthy cells. While immune checkpoint inhibitors have been effective in certain cancers, patients often relapse and eventually stop responding to or develop resistance to this type of treatment. Early research shows oncolytic viruses can prime a person’s immune system and increase the level of PD-L1 in tumors, making immunotherapy more effective against cancer.
https://www.cityofhope.org/first-patient-dosed-trial-cancer-killing-virus